| Literature DB >> 21993244 |
Yuliya Pylayeva-Gupta1, Elda Grabocka, Dafna Bar-Sagi.
Abstract
RAS proteins are essential components of signalling pathways that emanate from cell surface receptors. Oncogenic activation of these proteins owing to missense mutations is frequently detected in several types of cancer. A wealth of biochemical and genetic studies indicates that RAS proteins control a complex molecular circuitry that consists of a wide array of interconnecting pathways. In this Review, we describe how RAS oncogenes exploit their extensive signalling reach to affect multiple cellular processes that drive tumorigenesis.Entities:
Mesh:
Year: 2011 PMID: 21993244 PMCID: PMC3632399 DOI: 10.1038/nrc3106
Source DB: PubMed Journal: Nat Rev Cancer ISSN: 1474-175X Impact factor: 60.716